Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30

$0.68−0.04 (-5.28%)

Close on Nov 11, 2026Market cap $15.93MP/E –Yield –

Genenta Science S.p.A. operating margin

Operating margin is operating income as a percentage of revenue.

Genenta Science S.p.A. has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?